Table 5

Indicators of interactions with pharmaceutical companies analysed by country.
Country & no. of patient organisation websites
 Proportion of income from Pharma is clear
 Use of Pharma funding is clear
 Clear that Pharma funding is 'unrestricted'
 Pharma logos are present
 Pharma introductions present
 Evidence of Pharma sponsored events, etc.
 Links to Pharma websites present
Australia (n = 11)
 0
 0
 2
 4
 1
 1
 3
Canada (n = 12)
 0
 2
 1
 7
 3
 2
 6
S. Africa (n = 7)
 0
 0
 0
 3
 0
 0
 2
UK (n = 15)
 0
 3
 2
 5
 1
 2
 4
USA (n = 16)
 0
 5
 3
 2
 2
 5
 5
Global (n = 8)
 0
 1
 1
 2
 0
 2
 1
Total (n = 69) n [%]
 1 [1%]
 11 [16%]
 9 [13%]
 23 [33%]
 7 [10%]
 12 [17%]
 21 [30%]

Key: Pharma – pharmaceutical companies or industry

Ball et al. BMC Public Health 2006 6:201   doi:10.1186/1471-2458-6-201